SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-24-258788
Filing Date
2024-11-14
Accepted
2024-11-14 17:14:58
Documents
1
Group Members
COLUMN GROUP II GP, LPDAVID GOEDDELPETER SVENNILSON

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d851421dsc13ga.htm SC 13G/A 74076
  Complete submission text file 0001193125-24-258788.txt   75802
Mailing Address 1700 OWENS STREET SUITE 500 SAN FRANCISCO CA 94158
Business Address 1700 OWENS STREET SUITE 500 SAN FRANCISCO CA 94158 4158652050
COLUMN GROUP II, LP (Filed by) CIK: 0001600420 (see all company filings)

IRS No.: 211417046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 388-5600
Oric Pharmaceuticals, Inc. (Subject) CIK: 0001796280 (see all company filings)

IRS No.: 471787157 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91490 | Film No.: 241464275
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)